Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX

The FOLFOX scheme, based on the association of 5-fluorouracil and oxaliplatin, is the most frequently indicated chemotherapy scheme for patients diagnosed with metastatic colorectal cancer. Nevertheless, development of chemoresistance is one of the major challenges associated with this disease. It h...

Descripción completa

Detalles Bibliográficos
Autores principales: Escalante, Paula I., Quiñones, Luis A., Contreras, Héctor R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827270/
https://www.ncbi.nlm.nih.gov/pubmed/33429840
http://dx.doi.org/10.3390/pharmaceutics13010075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827270/
https://www.ncbi.nlm.nih.gov/pubmed/33429840
http://dx.doi.org/10.3390/pharmaceutics13010075

Ejemplares similares